Human papillomavirus testing and screening

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 19, Issue 4 SPEC. ISS., 2005, Pages 501-515

  Denny, L A ^a   Wright Jr , T C ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

Cervix neoplasms diagnosis; DNA; Papoviridae infections diagnosis; Tumour virus infections diagnosis; Viral analysis

Indexed keywords

VIRUS DNA;

CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; COLPOSCOPY; CONDYLOMA; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; REVIEW; RISK REDUCTION; SURGICAL APPROACH; SURGICAL TECHNIQUE; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

EID: 24644497697     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2005.02.004     Document Type: Review

References (55)

1. J. Ferlay F. Bray P. Pisani & D.M. Parking GLOBOCAN 2000. Cancer Incidence. Mortality and Prevalence Worldwide Version 1.0. IARC Cancer Base no. 5 2001 IARC Press Lyon
2. N. Munoz F.X. Bosch S. de Sanjose et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 348 2003 423-428
3. E. Laara N.E. Day & M. Hakama Trends in mortality from cervical cancer in the Nordic countries: Association with organised screening programmes Lancet 1 8544 1987 1247-1249
4. IARC Working Group on Evaluation of Cervical Cancer Screening Programmes Screening for squamous cervical cancer: The duration of low risk after negative result of cervical cytology and its implication for screening policies BMJ 293 1986 659-664
5. M. Hakama & K. Louhivuori A screening programme for cervical cancer that worked Cancer Surveys 17 1988 403-416
6. M. Hakama A.B. Miller & N.E. Day (eds.) Screening for Cancer of the Uterine Cervix IARC Scientific Publications no. 76 1986 International Agency for Research on Cancer Lyon 47-60
7. D.M. Parkin Screening for cervix cancer in developing countries In A.B. Miller J. Chamberlain N.E. Day M. Hakama & P.C. Prorok (eds.) Cancer Screening 1991 Cambridge University Press Cambridge 184-198
8. K. Nanda D.C. McCrory E.R. Myers et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review Ann Int Med 132 2000 810-819
9. M.T. Fahey L. Irwig & P. Macaskill Meta-analysis of Pap test accuracy Am J Epidemiol 141 1995 680-689
10. C.L. Peyton M. Schiffman A.T. Lorincz et al. Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies J Clin Microbiol 36 1998 3248-3254
11. T. Iftner & L.L. Villa Human papillomavirus technologies J Natl Cancer Inst Monogr 31 2003 80-88
12. P. Gravitt C.L. Peyton & T.Q. Alessi Improved amplification of genital papillomaviruses J Clin Microbiol 38 2000 357-361
13. M.H. Schiffman N.B. Kiviat R.D. Burk et al. Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture J Clin Microbiol 33 1995 545-550
14. P.E. Castle A.T. Lorincz I. Mielzynska-Lohnas et al. Results of human papillomavirus DNA testing with the hybrid capture 2 assay are reproducible J Clin Microbiol 40 3 2002 1088-1090
15. S. Kulasingam J. Hughes N. Kiviat et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities. Comparison of sensitivity, specificity and frequency of referral JAMA 288 2002 1749-1757
16. G.Y.F. Ho R. Bierman L. Beardsley et al. Natural history of cervicovaginal papillomavirus infection in young women N Engl J Med 338 1998 423-428
17. C.M. Wheeler C.E. Greer T.M. Becker et al. Short-term fluctuations in the detection of cervical human papillomavirus DNA Obstet Gynecol 88 1996 261-268
18. J. Cuzick P. Sasieni P. Davies et al. A systematic review of the role of human papillomavirus testing within a cervical screening programme Health Technol Asses 3 1999 61
19. A. Hildesheim M.H. Schiffman P.E. Gravitt et al. Persistence of type-specific human papillomavirus infection among cytologically normal women J Infect Dis 169 1994 235-240
20. M. Evander K. Edlund A. Gustafsson et al. Human papillomavirus infection is transient in young women: A population-based cohort study J Infect Dis 171 1995 1026-1030
21. A.B. Moscicki J.M. Palefsky G. Smith et al. Variability of human papillomavirus DNA testing in a longitudinal cohort of young women Obstet Gynecol 82 1993 578-585
22. J. Salmeron E. Lazcano-Ponce A. Lorincz et al. Comparison of HPV-based assays with Papanicoloau smears for cervical cancer screening in Morelos State, Mexico Cancer Causes Control 14 2003 505-512
23. M. Schiffman R. Herrero A. Hildesheim et al. HPV DNA testing in cervical cancer screening: Results from a high-risk province in Costa Rica JAMA 283 2000 87-93
24. L. Kuhn L. Denny A. Pollack & T.C. Wright Human papillomavirus DNA testing for cervical cancer screening in low-resource settings J Natl Cancer Inst 92 2000 818-825
25. J. Belinson Y.L. Qiao R. Pretorius et al. Shanxi province cervical cancer screening studies: A cross-sectional comparative trial of multiple techniques to detect cervical neoplasia Gynecol Oncol 83 2001 439-444
26. C. Clavel M. Masure J-P. Bory et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: A study of 7932 women Br J Cancer 89 2001 1616-1623
27. J. Cuzick E. Beverley L. Ho et al. HPV testing in primary screening of older women Br J Cancer 81 1999 554-558
28. K-U. Petry S. Menton M. Menton et al. Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8468 patients Br J Cancer 88 2003 1570-1577
29. E.L. Franco Primary screening of cervical cancer with human papillomavirus tests J Natl Cancer Inst Monogr 31 2003 89-96
30. M.E. Sherman A.T. Lorincz D.R. Scott et al. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: A 10-year cohort analysis J Natl Cancer Inst 95 2003 46-52
31. J. Cuzick A. Szarewski H. Cubie et al. Management of women who test positive for high-risk types of human papillomavirus: The HART study Lancet 362 2003 1871-1876
32. L. Denny L. Kuhn A. Pollack et al. Two stage cervical cancer screening: an alternative for resource poor settings Am J Obstet Gynecol 283 2000 81-86
33. Denny, L. An evaluation of alternative strategies for the prevention of cervical cancer in low-resource settings. PhD Thesis. University of Cape Town; 2000.
34. P.E. Castle S. Wacholder M.E. Sherman et al. Absolute risk of a subsequent abnormal Pap among oncogenic human papillomavirus DNA-positive cytologically negative women Cancer 95 2002 2145-2151
35. L. Koutsky K. Holmes M. Crichlow et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection N Engl J Med 327 1992 1272-1278
36. L. Rozendal J.M. Walboomers J.C. van der Linden et al. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytologically normal cervical smears Int J Cancer 68 1996 766-769
37. T.C. Wright L. Denny L. Kuhn et al. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer JAMA 283 2000 81-86
38. J.L. Belinson Y.L. Qiao R.G. Pretorius et al. Shanxi Province cervical cancer screening study II: Self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomvirus and liquid based cervical cytology Int J Gynecol Cancer 13 2003 819-826
39. M. Schiffman & M.E. Adrianza ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants Acta Cytol 124 2000 203-211
40. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: Baseline data from a randomised trial J Natl Cancer Inst 92 2000 397-402
41. T.C. Wright M. Schiffman D. Solomon et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening Obstet Gynecol 103 2004 304-309
42. D. Solomon M. Schiffman & R. Tarone Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomised trial J Natl Cancer Inst 93 2001 293-299
43. M. Manos W.K. Kinney L.B. Hurley et al. Identifying women with cervical neoplasia: Using human papillomavirus DNA testing for equivocal Papanicolaou results JAMA 281 1999 1605-1610
44. J.J. Kim T.C. Wright & S.J. Goldie Cost-effectiveness of alternative strategies for atypical squamous cells of undetermined significance JAMA 287 2002 2382-2390
45. M.E. Sherman M. Schiffman & J.T. Cox Effects of age and human papilloma viral load on colposcopy triage: Data from the Randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS) J Natl Cancer Inst 94 2002 102-107
46. T.C. Wright J.T. Cox L. Massad et al. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities JAMA 287 2002 2120-2129
47. M.F. Mitchell G. Tortolero-Luna E. Cook et al. A randomised clinical trial of cryotherapy, laser vaporisation, and loop electrosurgical excision for treatment of squamous intraepithelial lesions of the cervix Obstet Gynecol 92 1998 737-744
48. W.P. Soutter A. de Barros Lopes & A. Fletcher Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia Lancet 349 1997 978-980
49. A.T. Lorincz Screening for cervical cancer: New alternatives and research Salud Publica Mex 45 supplement 3 2003 S376-S387
50. E. Paraskevaidis G. Koliopoulos Y. Alamanos et al. Human papillomavirus testing and the outcome of treatment for cervical intraepithelial neoplasia Obstet Gynecol 98 2001 833-836
51. E. Paraskevaidis M. Arbyn A. Sotiriadis et al. The role of HPV DNA testing in the follow-up period after treatment for CIN: A systematic review of the literature Cancer Treat Rev 30 2004 205-211
52. M.A.E. Nobbenhuis C.J.L.M. Meijer A.J.C. van der Brule et al. Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intra-epithelial neoplasia Br J Cancer 84 2001 940-945
53. X.W. Sun L. Kuhn T.V. Ellerbrock M.A. Chiasson et al. Human papilloma virus infection in women infected with the human immunodeficiency virus N Engl J Med 337 1997 1343-1349
54. J.M. Palefsky H. Minkoff L.A. Kalish et al. Cervicovaginal human papilloma virus infection in human immunodeficiency virus-1 (HIV)-positive and high risk HIV negative women J Natl Cancer Inst 91 1999 226-236
55. T.V. Ellerbrock M.A. Chiasson T.J. Bush et al. Incidence of cervical squamous intraepithelial lesions in HIV infected women JAMA 283 2000 1031-1037